MedTrace Logo

Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)

NCT02443571 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 714

Last updated 2018-12-19

Study results available
· View outcomes & findings →

Summary

This retrospective observational multi centered study has been established to collect the clinical experience relating to the administration of Fluciclovine 18F employed in both investigator initiated studies and named patient/compassionate use programmes in up to 5 sites.

Conditions

  • Prostatic Neoplasms

Interventions

RADIATION

Fluciclovine (18F)

Not applicable. This is an observational study.

Sponsors & Collaborators

  • Blue Earth Diagnostics

    lead INDUSTRY

Principal Investigators

  • Penelope Ward, MBBS FFPM · Blue Earth Diagnostics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States
  • Italy
  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02443571 on ClinicalTrials.gov